Carine Chaleteix

3.7k total citations
22 papers, 607 citations indexed

About

Carine Chaleteix is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Carine Chaleteix has authored 22 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Carine Chaleteix's work include Multiple Myeloma Research and Treatments (15 papers), Cancer Treatment and Pharmacology (8 papers) and Protein Degradation and Inhibitors (6 papers). Carine Chaleteix is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Cancer Treatment and Pharmacology (8 papers) and Protein Degradation and Inhibitors (6 papers). Carine Chaleteix collaborates with scholars based in France, United States and Brazil. Carine Chaleteix's co-authors include Nicolas Kerckhove, David Balayssac, Denis Pezet, Aurore Collin, Olivier Tournilhac, Thierry Façon, Michel Attal, Denis Caillot, Philippe Travade and Alain Fischer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Carine Chaleteix

21 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carine Chaleteix France 9 329 256 192 121 94 22 607
Yuichi Konuma Japan 9 142 0.4× 176 0.7× 184 1.0× 91 0.8× 38 0.4× 16 490
Neil Majithia United States 12 398 1.2× 147 0.6× 159 0.8× 15 0.1× 84 0.9× 19 565
Cynthia Hartley United States 12 228 0.7× 350 1.4× 92 0.5× 76 0.6× 34 0.4× 25 547
Kiyotaka Kawauchi Japan 15 156 0.5× 207 0.8× 279 1.5× 220 1.8× 132 1.4× 36 806
Robert Chew United States 6 90 0.3× 86 0.3× 63 0.3× 66 0.5× 45 0.5× 8 438
Adrian Tempescul France 12 110 0.3× 89 0.3× 125 0.7× 133 1.1× 18 0.2× 46 408
Emma Searle United Kingdom 11 91 0.3× 104 0.4× 104 0.5× 47 0.4× 18 0.2× 28 359
Steve Abella United States 9 68 0.2× 62 0.2× 110 0.6× 133 1.1× 53 0.6× 21 386
Ruirong Yuan United States 9 204 0.6× 76 0.3× 209 1.1× 54 0.4× 37 0.4× 11 470
Dorian LaTocha United States 13 87 0.3× 190 0.7× 238 1.2× 199 1.6× 28 0.3× 19 663

Countries citing papers authored by Carine Chaleteix

Since Specialization
Citations

This map shows the geographic impact of Carine Chaleteix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carine Chaleteix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carine Chaleteix more than expected).

Fields of papers citing papers by Carine Chaleteix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carine Chaleteix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carine Chaleteix. The network helps show where Carine Chaleteix may publish in the future.

Co-authorship network of co-authors of Carine Chaleteix

This figure shows the co-authorship network connecting the top 25 collaborators of Carine Chaleteix. A scholar is included among the top collaborators of Carine Chaleteix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carine Chaleteix. Carine Chaleteix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touzeau, Cyrille, Xavier Leleu, Mourad Tiab, et al.. (2024). All-oral triplet iberdomide, ixazomib, and dexamethasone in elderly patients with multiple myeloma at first relapse: Results of the IFM phase 2 study I2D.. Journal of Clinical Oncology. 42(16_suppl). 7507–7507. 1 indexed citations
2.
Balayssac, David, Bruno Pereira, Carine Chaleteix, et al.. (2023). Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study. European Journal of Cancer Care. 2023. 1–9.
3.
Giraudet, Fabrice, Marie Selvy, Nicolas Kerckhove, et al.. (2022). Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study. European Archives of Oto-Rhino-Laryngology. 279(4). 2197–2201. 3 indexed citations
4.
Selvy, Marie, Nicolas Kerckhove, Bruno Pereira, et al.. (2021). Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study. Frontiers in Pharmacology. 12. 637593–637593. 34 indexed citations
5.
Nourrisson, Céline, et al.. (2021). Cerebral aspergillosis in a patient on ibrutinib therapy. British Journal of Haematology. 193(6). 1025–1025. 3 indexed citations
6.
Kerckhove, Nicolas, Aurore Collin, Carine Chaleteix, et al.. (2018). Neuropathies périphériques chimio-induites : symptomatologie et épidémiologie. Bulletin du Cancer. 105(11). 1020–1032. 10 indexed citations
7.
Lemal, Richard, et al.. (2017). Pomalidomide dans les myélomes multiples. Bulletin du Cancer. 104(9). 707–713. 2 indexed citations
8.
9.
Moreau, Philippe, Brigitte Kolb, Michel Attal, et al.. (2015). Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma. Blood. 125(20). 3100–3104. 39 indexed citations
10.
Perbet, Sébastien, Romain Guièze, Richard Lemal, et al.. (2014). Lung Postmortem Autopsy Revealing Extramedullary Involvement in Multiple Myeloma Causing Acute Respiratory Distress Syndrome. SHILAP Revista de lepidopterología. 2014. 1–3. 7 indexed citations
11.
12.
Lemal, Richard, et al.. (2013). Large granular lymphocytic leukemia associated with Lambert–Eaton Myasthenic Syndrome: A case report. Leukemia Research Reports. 2(1). 32–33. 3 indexed citations
13.
14.
15.
16.
Tamburini, Jérôme, Vincent Lévy, Carine Chaleteix, et al.. (2005). Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients. Leukemia. 19(10). 1831–1834. 46 indexed citations
17.
Villemagne, Bruno, Jacques‐Olivier Bay, Olivier Tournilhac, Carine Chaleteix, & Philippe Travade. (2004). Two new cases of familial hairy cell leukemia associated with HLA haplotypes A2, B7, Bw4, Bw6. Leukemia & lymphoma. 46(2). 243–245. 8 indexed citations
18.
Tchirkov, Andréï, Carine Chaleteix, Christian Magnac, et al.. (2004). hTERT expression and prognosis in B-chronic lymphocytic leukemia. Annals of Oncology. 15(10). 1476–1480. 37 indexed citations
19.
20.
Quartier, Pierre, Olivier Tournilhac, Christine Archimbaud, et al.. (2003). Enteroviral Meningoencephalitis after Anti‐CD20 (Rituximab) Treatment. Clinical Infectious Diseases. 36(3). e47–e49. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Konuma Breakdown of academic impact, for papers by Neil Majithia Breakdown of academic impact, for papers by Cynthia Hartley Breakdown of academic impact, for papers by Kiyotaka Kawauchi Breakdown of academic impact, for papers by Robert Chew Breakdown of academic impact, for papers by Adrian Tempescul Breakdown of academic impact, for papers by Emma Searle Breakdown of academic impact, for papers by Steve Abella Breakdown of academic impact, for papers by Ruirong Yuan Breakdown of academic impact, for papers by Dorian LaTocha
Rankless by CCL
2026